Related Experiment Video
Updated: May 12, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
The Effect of Health Insurance on Racial Disparities in Patients With Isolated Colorectal Liver Metastases
Anastasios T Mitsakos1, Scarlett Hao2, Michael D Honaker2
1Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA.
Black patients with colorectal liver metastases (CRLM) had lower resection rates. Health insurance, particularly private and Medicare, exacerbated these racial disparities in CRLM resection.
Area of Science:
- Oncology
- Health Services Research
- Surgical Oncology
Background:
- Colorectal liver metastases (CRLM) significantly impact patient survival.
- Existing disparities in CRLM care are linked to patient race and health insurance status.
- Understanding these disparities is crucial for equitable treatment strategies.
Purpose of the Study:
- To investigate the influence of health insurance on racial disparities in the surgical resection of colorectal liver metastases (CRLM).
- To determine if insurance status modifies the association between race and CRLM resection rates.
Main Methods:
- Retrospective analysis of 44,616 patients with colorectal cancer and synchronous CRLM from the National Cancer Database (2004-2020).
- Primary outcome assessed was the rate of liver resection.
- Multivariable logistic regression was employed to analyze the association of race and insurance with resection odds.
Main Results:
- Overall CRLM resection rates were lower in Black patients (12.9%) compared to White patients (17.3%).
- Black patients, uninsured, and Medicaid-insured patients demonstrated significantly lower odds of undergoing resection compared to White and privately insured patients, respectively.
- When stratified by insurance, Black patients with private and Medicare insurance showed reduced odds of resection compared to their White counterparts.
Conclusions:
- Racial disparities in CRLM hepatic resection exist, with Black patients having lower odds.
- These disparities are particularly evident among Black patients with private and Medicare insurance.
- Further research is needed to identify underlying factors contributing to these observed racial disparities in CRLM treatment.
More Related Videos
04:22Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
Published on: March 3, 2023
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test